Advertisement

An integrated molecular modeling approach for the tryptase monomer–curcuminoid recognition analysis: conformational and bioenergetic features

  • Pathomwat Wongrattanakamon
  • Chadarat Ampasavate
  • Busaban Sirithunyalug
  • Supat Jiranusornkul
Article
  • 40 Downloads

Abstract

Human mast cell tryptase has been shown as an activating enzyme in matrix degradation process. The previous study suggest that tryptase either alone or in joining with activation of metalloproteinases, can associate in extra cellular matrix damage and the possible destruction of the basement membrane resulting in photoaging. Therefore the inhibition of tryptase activity is one of the most important therapeutic strategies against the photoaging. Curcumin has been shown to be a potential agent for preventing and/or treating the photoaging induced by UV radiation. However, the protective effect of curcumin against the photoaging through the tryptase inhibition is still inadequately understood. In this work, computational methods to characterize the structural framework and define the atomistic details of the determinants for the tryptase inhibition mechanism by curcuminoids were performed. By molecular docking, three putative binding models able to efficiently bind all curcuminoids were identified. Analysis of molecular dynamics simulations revealed that cyclocurcumin, curcumin glucuronide, and curcumin, the most effective inhibitors from the three models, modified significant tryptase monomer rigidity by binding in all the possible sites. The result of these binding events is the suppression of the functional enzymatic motions involving the binding of substrates to the catalytic site. On the basis of this finding may thus be beneficial for the development of new natural inhibitors for the therapeutic remedy of photoaging, targeting and modulating the activity of tryptase.

Keywords

Anti-aging Curcuma longa Curcuminoids Molecular docking Molecular dynamics simulation Photoaging Tryptase 

Notes

Acknowledgements

The authors would like to thank Inte:Ligand Software-Entwicklungs und Consulting GmbH for providing an academic free license for LigandScout 4.2.1.

Compliance with ethical standards

This article does not contain any study with human or animal subjects performed by any of the authors.

Conflict of interest

Every author declares no conflict of interest.

References

  1. Barik A, Mishra B, Kunwar A, Indira Priyadarsini K (2007) Interaction of curcumin with human serum albumin: thermodynamic properties, fluorescence energy transfer and denaturation effects. Chem Phys Lett 436:239–243.  https://doi.org/10.1016/j.cplett.2007.01.006 CrossRefGoogle Scholar
  2. Cairns JA (2005) Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders. Pulm Pharmacol Ther 18:55–66.  https://doi.org/10.1016/j.pupt.2004.09.032 CrossRefPubMedGoogle Scholar
  3. Case DA, IYB-S SR, Brozell DS, Cerutti TE, Cheatham VWD III, Cruzeiro TA, Darden RE, Duke D, Ghoreishi MK, Gilson H, Gohlke AW, Goetz D, Greene R, Harris N, Homeyer S, Izadi A, Kovalenko T, Kurtzman TS, Lee S, LeGrand P, Li C, Lin J, Liu T, Luchko R, Luo DJ, Mermelstein KM, Merz Y, Miao G, Monard C, Nguyen H, Nguyen I, Omelyan A, Onufriev F, Pan R, Qi DR, Roe A, Roitberg C, Sagui S, Schott-Verdugo J, Shen CL, Simmerling J, Smith R, Salomon-Ferrer J, Swails RC, Walker J, Wang H, Wei RM, Wolf XW, Xiao L, York DM, Kollman PA (2018) AMBER 2018. University of California, San FranciscoGoogle Scholar
  4. Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092.  https://doi.org/10.1063/1.464397 CrossRefGoogle Scholar
  5. Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee T, Caldwell J, Wang J, Kollman P (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 24:1999–2012.  https://doi.org/10.1002/jcc.10349 CrossRefPubMedGoogle Scholar
  6. Fukuoka Y, Schwartz LB (2004) Human β-Tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors. Biochemistry 43:10757–10764.  https://doi.org/10.1021/bi049486c CrossRefPubMedGoogle Scholar
  7. Gupta SC, Prasad S, Kim JH, Patchva S, Webb LJ, Priyadarsini IK, Aggarwal BB (2011) Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep 28:1937–1955.  https://doi.org/10.1039/c1np00051a CrossRefPubMedPubMedCentralGoogle Scholar
  8. Hetenyi C, van der Spoel D (2006) Blind docking of drug-sized compounds to proteins with up to a thousand residues. FEBS Lett 580:1447–1450.  https://doi.org/10.1016/j.febslet.2006.01.074 CrossRefPubMedGoogle Scholar
  9. Hung CF, Chen WY, Aljuffali IA, Lin YK, Shih HC, Fang JY (2015) Skin aging modulates percutaneous drug absorption: the impact of ultraviolet irradiation and ovariectomy. Age (Dordr) 37(21):21.  https://doi.org/10.1007/s11357-015-9757-1 CrossRefGoogle Scholar
  10. Iddamalgoda A, Le QT, Ito K, Tanaka K, Kojima H, Kido H (2008) Mast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteins. Arch Dermatol Res 300(Suppl 1):S69–S76.  https://doi.org/10.1007/s00403-007-0806-1 CrossRefPubMedPubMedCentralGoogle Scholar
  11. Indira Priyadarsini K (2013) Chemical and structural features influencing the biological activity of curcumin. Curr Pharm Des 19:2093–2100.  https://doi.org/10.2174/138161213805289228 CrossRefPubMedGoogle Scholar
  12. Jiang QQ, Bartsch L, Sicking W, Wich PR, Heider D, Hoffmann D, Schmuck C (2013) A new approach to inhibit human beta-tryptase by protein surface binding of four-armed peptide ligands with two different sets of arms. Org Biomol Chem 11:1631–1639.  https://doi.org/10.1039/c3ob27302d CrossRefPubMedGoogle Scholar
  13. Kamal MZ, Mohammad TAS, Krishnamoorthy G, Rao NM (2012) Role of active site rigidity in activity: MD simulation and fluorescence study on a lipase mutant. PLoS One 7:e35188.  https://doi.org/10.1371/journal.pone.0035188 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Liang G, Aldous S, Merriman G, Levell J, Pribish J, Cairns J, Chen X, Maignan S, Mathieu M, Tsay J, Sides K, Rebello S, Whitely B, Morize I, Pauls HW (2012) Structure-based library design and the discovery of a potent and selective mast cell beta-tryptase inhibitor as an oral therapeutic agent. Bioorg Med Chem Lett 22:1049–1054.  https://doi.org/10.1016/j.bmcl.2011.11.119 CrossRefPubMedGoogle Scholar
  15. Liu W, Huang B, Kuang Y, Liu G (2017) Molecular dynamics simulations elucidate conformational selection and induced fit mechanisms in the binding of PD-1 and PD-L1. Mol BioSyst 13:892–900.  https://doi.org/10.1039/c7mb00036g CrossRefPubMedGoogle Scholar
  16. Muta K, Inomata S, Fukuhara T, Nomura J, Nishiyama T, Tagawa YI, Amano S (2018) Inhibitory effect of the extract of rhizome of Curcuma longa L in gelatinase activity and its effect on human skin. J Biosci Bioeng 125:353–358.  https://doi.org/10.1016/j.jbiosc.2017.10.001 CrossRefPubMedGoogle Scholar
  17. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera--a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612.  https://doi.org/10.1002/jcc.20084 CrossRefPubMedGoogle Scholar
  18. Punkvang A, Hannongbua S, Saparpakorn P, Pungpo P (2016) Insight into the structural requirements of aminopyrimidine derivatives for good potency against both purified enzyme and whole cells of M. tuberculosis: combination of HQSAR, CoMSIA, and MD simulation studies. J Biomol Struct Dyn 34:1079–1091.  https://doi.org/10.1080/07391102.2015.1068711 CrossRefPubMedGoogle Scholar
  19. Rout AK, Dehury B, Maharana J, Nayak C, Baisvar VS, Behera BK, Das BK (2018) Deep insights into the mode of ATP-binding mechanism in zebrafish cyclin-dependent protein kinase-like 1 (zCDKL1): a molecular dynamics approach. J Mol Graph Model 81:175–183.  https://doi.org/10.1016/j.jmgm.2018.02.002 CrossRefPubMedGoogle Scholar
  20. Stennicke HR, Ryan CA, Salvesen GS (2002) Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem Sci 27:94–101CrossRefGoogle Scholar
  21. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A, Kalogeromitros D (2012) Mast cells and inflammation. Biochim Biophys Acta 1822:21–33.  https://doi.org/10.1016/j.bbadis.2010.12.014 CrossRefPubMedGoogle Scholar
  22. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157–1174.  https://doi.org/10.1002/jcc.20035 CrossRefPubMedPubMedCentralGoogle Scholar
  23. Wolber G, Langer T (2005) LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 45:160–169.  https://doi.org/10.1021/ci049885e CrossRefPubMedGoogle Scholar
  24. Yodkeeree S, Chaiwangyen W, Garbisa S, Limtrakul P (2009) Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem 20:87–95.  https://doi.org/10.1016/j.jnutbio.2007.12.003 CrossRefPubMedGoogle Scholar
  25. Zlotogorski A (1987) Distribution of skin surface pH on the forehead and cheek of adults. Arch Dermatol Res 279:398–401CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Laboratory for Molecular Design and Simulation (LMDS), Department of Pharmaceutical Sciences, Faculty of PharmacyChiang Mai UniversityChiang MaiThailand
  2. 2.Department of Pharmaceutical Sciences, Faculty of PharmacyChiang Mai UniversityChiang MaiThailand

Personalised recommendations